Nature of cervical cancer and other HPV - Associated cancers

Journal of B.U.ON.

Volumn 14, Issue 3, 2009, Pages 391-398

  Georgieva, Stoyanka ^a   Iordanov, V ^a   Sergieva, S ^b  

^a National Oncology Center Bulgaria   (Bulgaria)

^b Sofia Cancer Centre   (Bulgaria)

Author keywords

Cervical cancer; HPV types; HPV associated cancers

Indexed keywords

VIRUS DNA;

ANUS CANCER; BOWEN DISEASE; BREAST CANCER; BUSCHKE LOWENSTEIN TUMOR; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONDYLOMA ACUMINATUM; EPITHELIUM CELL; GENITAL TRACT CANCER; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION SENSITIVITY; LUNG CANCER; PENIS CANCER; POLYMERASE CHAIN REACTION; PROSTATE CANCER; REVIEW; SEXUAL TRANSMISSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CANCER; VAGINAL INTRAEPITHELIAL NEOPLASIA; VERRUCOUS CARCINOMA; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS TYPING; VULVA CARCINOMA; WART VIRUS;

BOWEN'S DISEASE; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONDYLOMATA ACUMINATA; EPITHELIAL CELLS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSTATIC NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 70350040946     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Munder K, Howley PM. Human papillomavirus immortalization and transformation function. Virus Res 2002; 89: 213-228.
2. Munoz N, Bosch XF, De Sanjoses et al. Epidemiologic classification of human papilloma virus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527. (Pubitemid 36159887)
3. Stewart BW, Kleihues P (Eds): World Cancer Report. IARC Press. Lyon 2003, p 215.
4. Zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977; 78: 1-30.
5. Baseman JG Koutsky LA. The epidemiology of human papillomavirus infection. J Clin Virol 2005; 32 (Suppl 1): 516-524.
6. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184: 9-13.
7. International Agency for Research on Cancer. Evaluation of Carcinogenic Risk in Humans: Human papillomavirus. Lyon, France: IARC; 2006. IARC Monograph, 2005.
8. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 9-12.
9. Zlatkov V, Kostova P, Makaveeva V, Ganchev G, Danon S. A study on the cervical epithelium of women in early pregnancy - histological findings and human papillomavirus characterization. J BUON 2003; 8: 269-272. (Pubitemid 37441423)
10. von Knebel, Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002; 38: 2229-2242.
11. Duensing S, Munger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 2004; 109: 157-162. (Pubitemid 38240914)
12. Rutledge F. Cancer of the vagina. Am J Obstet Gynecol 1967; 97: 635-655.
13. Sillman FH, Sedlis A, Boyce JG. A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil. Obstet Gynecol Surv 1985; 40: 190-220. (Pubitemid 15112479)
14. Gallp DG, Morley GW. Carcinoma in situ of the vagina. A study and review. Obstet Gynecol 1975; 46: 334-340.
15. Minucci A, Cinel A, Insacco E et al. Epidemiological aspects of vaginal intraepithelial neoplasia (VAIN). Clin Exp Obstet Gynecol 1995; 22: 36-42.
16. Sugase M, Matsukura T. Distinct manifestations of human papillomaviruses in the vagina. Int J Cancer 1997; 72: 412-415. (Pubitemid 27325867)
17. Georgieva S, Iordanov V. A woman with synchronous cervical, vaginal and laryngeal squamous cell carcinomas and positive human papillomavirus type 16; case presentation with literature review. J BUON 2008; 13: 109-113.
18. Sillman FH, Frachter RG, Chen YS et al. Vaginal intraepithelial neoplasia: risk factors per persistence, recurrence and invasion and its management. Am J Obstet Gynecol 1997; 176: 93-99.
19. Frega A, French D, Piazze J et al. Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection. Cancer Lett 2007; 249: 235-241. (Pubitemid 46452931)
20. Gupta J, Pilotti S, Rilke F, Shah K. Association of human papillomavirus type 16 with neoplastic lesions of the vulva and other genital sites by in situ hybridization. Am J Pathol 1987; 127: 206-215. (Pubitemid 17086956)
21. Hording U, Daugard S, Iversen T et al. Human papillomavirus type 16 in vulvar carcinoma, vulvar intraepithelial neoplasia, and associated cervical neoplasia. Gynecol Oncol 1991; 42: 22-26.
22. Park JS, Jones RW, Mc Lean MR et al. Possible etiologic heterogeneity of vulvar intraepithelial neoplasia. A correlation of pathologic characteristics with human papillomavirus detection by in situ hybridization and polymerase chain reaction. Cancer 1991; 67: 1599-11507
23. Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol 1994; 84: 741-745.
24. Jones RW, Baranyai J, Stable S. Trends in squamous cell carcinoma of the vulva: influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997; 90: 448-452. (Pubitemid 27357940)
25. Beutner KR, Spruance SL, Houghham AJ et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998; 38: 230-239. (Pubitemid 28100838)
26. Fehr MK, Homung R, Schwarz VA et al. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulenic acid. Gynecol Oncol 2001; 80: 62-66.
27. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. J Obstet Gynecol 2005; 106: 1319-1326.
28. Kirwan JM, Herod JJ. Premalignant vulval disorders. Curr Obst Gynecol 2002; 12: 90-96.
29. Wiley DJ, Douglas J, Beutner K et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002; 35: S210-S224. (Pubitemid 35178333)
30. Derkay CS, Darrow DH. Recurrent respiratory papillomatosis of the larynx: current diagnosis and treatment, Otolaryngol Clin North Am 2000; 33: 1127-1141. (Pubitemid 30703828)
31. Crum CP, Mitao M, Levine RU, Silverstein S. Cervical papilloma viruses segregate within morphologically distinct precancerous lesions. J Virol 1985; 54: 675-681. (Pubitemid 15227230)
32. Willett GD, Kurman RJ, Reid R, Greenberg M, Jenson AB, Lorincz AT. Correlation of the histologic appearance of intraepithelial neoplasia of the cervix with human papillomavirus types: emphasis on low grade lesions including so-called flat condyloma. Int J Gynecol Pathol 1989; 8: 18-25. (Pubitemid 19076258)
33. Hippelainen M, Yliskoski M, Saarikoski S, Syrjanen S, Syrjanen K. Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy. Genitourin Med 1991; 67: 291-296.
34. Barrasso R, de Brux J, Croissant O, Orth G. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987; 317: 916-923. (Pubitemid 17147933)
35. Bleeker MC, Hogewoning CJ, van den Brule AJ et al. Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol 2002; 47: 351-357.
36. Van Howe RS. Human papilloma virus and circumcision: A meta-analysis. J Infect 2007; 54: 490-496. (Pubitemid 46567503)
37. Ihin CW, Park SL, Sung SY, Lee IS. Bowenoid epidemiotopic metastatic squamous cell carcinoma. J Cutan Pathol 1996; 23: 479-484. (Pubitemid 26364555)
38. Collina G, Rossi E, Bettelli S et al. Detection of human papillomavirus in extragenital Bowens disease using in situ hybridization and polymerase chain reaction. Am J Dermatopathol 1995; 17: 236-241.
39. Ikenberg H, Gissmann L, Gross G, Grassendorf-Conen EI, zur Hausen H. Human papillomavirus type-16-related DNA in genital Bowens disease and in Bowenoid papulosis. Int J Cancer 1983; 32: 563-565. (Pubitemid 14247898)
40. Wade TR, Kopf AW, Ackerman AB. Bowenoid papulosis of the genitalia. Arch Dermatol 1979; 115: 306-308.
41. Lehn H, Ernst TM, Sauer G. Transcription of episomal papillomavirus DNA in human condylomata acuminate and Buschke-Lowenstein tumours. J Gen Virol 1984; 65: 2003-2010. (Pubitemid 15205776)
42. Band V, Zajchowski D, Kulesa V, Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 1990; 87: 463-467. (Pubitemid 20033091)
43. Liang W, Tian H. Hypothetic association between human papillomavirus infection and breast carcinoma. Med Hypotheses 2008; 70: 305-307. (Pubitemid 350297616)
44. Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G. Breast cancer and human papillomavirus (HPV) infection: No evidence of a viral etiology in a group of Swiss women. The Breast 2007; 16: 172-177.
45. Kroupis C, Markou A, Vourlidis N et al. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006; 39: 727-731. (Pubitemid 44036781)
46. Widschwendter A, Branhuber T, Wiedemair A, Holzner EM, Marth Chr. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 2004; 31: 292-297. (Pubitemid 39371063)
47. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32 (Suppl): S59-S66. (Pubitemid 40332590)
48. El Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 2001; 96: 2013-2018. (Pubitemid 32660891)
49. Wen S, Tsuji T, Li X. Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 1997; 17: 307-311. (Pubitemid 27116684)
50. Mitsuishi T, Kawana S, Kato T, Kawashima M. Human papillomavirus infection in actinic keratosis and Bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21Waf1/Cip1, p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions. Human Pathol 2003; 34: 886-892.
51. Herrero R. Human papillomavirus and cancer of the upper aerodigestive tract. Natl Cancer Inst Monographs, Ch 7, 2003; 31: 47-51.
52. Dahlstrom RK, Adler - Storthz K, Etzel JC et al. Human papillomavirus type 11, 16 infection and squamous cell carcinoma of the head and neck in never smokers. Clin Cancer Res 2003; 9: 2620-2626.
53. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92; 709-720.
54. Sugiyama M, Bhawal UK, Kawamura M et al. Human papillomavirus 16 in oral squamous cell carcinoma: Clinical correlates and 5-year survival. Br J Oral Maxillofacial Surg 2007; 45: 116-122. (Pubitemid 46131998)
55. Sutcliffe S, Giovannucci E, Gaydos CA et al. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1573-1580. (Pubitemid 47294821)
56. Al Moustafa AE. Involvement of human papillomavirus infections in prostate cancer progression. Med Hypotheses 2008; 71: 209-211.
57. Strickler HD, Burk R, Shah K et al. A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 1998; 82: 1118-1125. (Pubitemid 28136526)
58. Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 763-768.
59. Hemminki K, Dong C, Vaittinen P. Second primary cancer after in situ and invasive cervical cancer. Epidemiology 2000; 11: 457-461. (Pubitemid 30428941)
60. Kalliala I, Anttila A, Pukkala E, Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 2005; 331: 1183-1185. (Pubitemid 41689433)
61. Frisch M, Glimelins B, Van den Brule AJC et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-1358. (Pubitemid 27467769)
62. Kirgan D, Manalo P, Hall M, McGregor B. Association of human papilloma virus and colon neoplasm. Arch Surg 1990; 125: 862-865. (Pubitemid 20218801)
63. Cheng JY, Sheu LF, Meng CL, Lee WH, Lin JC. Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut 1995; 37: 87-90.
64. Perez LO, Abba MC, Languens RM, Golijow CD. Analysis of adenocarcinomas of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis 2005; 7: 492-495.
65. Bodaghi S, Yamanegi K, Xiao SY, da Costa M, Palefski JM, Zheng ZM. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005; 11: 2862-2867. (Pubitemid 40525184)
66. Damin DC, Caetano MB, Rosito MA et al. Evidence for an association of human papillomavirus infection and colorectal cancer. EJSO 2007; 33: 569-574. (Pubitemid 46746534)
67. Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol 2002; 55: 885-891.
68. Brochest L, Valmary S, Dahan M et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 2005; 92: 743-746. (Pubitemid 40460612)
69. Chiou HL, Wu MF, Liaw YC et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 2003; 97: 1558-1563.
70. Leggatt GR, Frazer IH. HPV vaccines: the beginning of the end for cervical cancer. Curr Opin Immunol 2007; 19: 232-238. (Pubitemid 46356961)
71. Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 2004; 4: 46-55.